The effect of tnf*b gene polymorphism on tnf-α and -β secretion levels in patients with insulin-dependent diabetes mellitus and healthy controls

International Journal of Immunogenetics

Volumn 23, Issue 6, 1996, Pages 425-435

  Whichelow, C E ^a   Hitman, G A ^a   Raafat, I ^a   Bottazzo, G F ^a   Sachs, J A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA; HLA B ANTIGEN; HLA DR ANTIGEN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA POLYMORPHISM; GENOTYPE; HLA TYPING; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN SECRETION; CELL CULTURE; CLASSIFICATION; CYTOLOGY; GENETIC POLYMORPHISM; GENETICS; HAPLOTYPE; IMMUNOLOGY; MONONUCLEAR CELL;

CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; GENOTYPE; HAPLOTYPES; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOTOXIN-ALPHA; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029658519     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.1996.tb00133.x     Document Type: Article

References (31)

1. Badenhoop, K., Schwarz, G., Trowsdale, J., Lewis, V., Usadel, K.U., Gale, E.A.M. & Bottazzo, G.F. (1989) TNF α gene polymorphism in type I (insulin-dependent) diabetes mellitus. Diabetologia, 32, 445.
2. Bettinotti, M.P., Hartung, K., Deicher, H., Messer, G., Keller, E., Weiss, E.H. & Albert, E.D. (1993) Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes. Immunogenetics, 37, 449.
3. Beutler, B. & Cerami, A. (1989) The Biology of Cachetin/TNF - a primary mediator of the host response. Annual Review of Immunology, 7, 625.
4. Cavan, D.A., Penny, M.A., Jacobs, K.H., Kelly, M.A., Jenkins, D., Mijovic, C.H., Chow, C.C., Cockram, C.S., Hawkins, B.R. & Barnett, A.H. (1994) Analysis of a Chinese population suggests that the TNFB gene is not a susceptibility gene for Graves' Disease. Hum Immunology, 40(2): 135.
5. Cox, A., Gonzalez, A.M., Wilson, A.G., Wilson, R.M., Ward, J.D., Artlett, C.M., Welsh, K. & Duffy, G.W. (1994) Comparative analysis of the genetic associations of HLA-DR3 and tumour necrosis factor alpha with human IDDM. Diabetologia, 37(5), 500.
6. Cuturi, M.C., Murphy, M., Costa-Giomi, M.P., Weinman, R., Perussia, B. & Trinchieri, G. (1987) Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. Journal of Experimental Medicine, 165, 1581.
7. Fennessy, M., Metcalf, K.A., Hitman, S. A. Niven, M.J., Biro, A., Tuomilehto, J., Tuomilehto-Wolf, E. & The Dime Study Group (1994) A gene in the HLA Class I region contributes to the susceptibility to Type I diabetes in the Finnish population. Diabetologia, 37, 939.
8. Ilonen, J., Merivuori, H., Reijonen, H., Knip, M., Ackerblom, H.K., Pociot, F. & Nerup, J. (1992) Tumour necrosis factor-beta gene RFLP alleles in Finnish IDDM haplotypes. The Childhood Diabetes in Finland (DiMe) Study Group. Scandinavian Journal of Immunology, 36, 779.
9. Jacob, C. & McDevitt, H.O. (1988) Tumour necrosis factor a in murine autoimmune ‘lupus’ nephritis. Nature, 331, 356.
10. Jacob, C., Fronek, Z., Lewis, G.D., Koo, M., Hansen, J.A. & McDevitt, H.O. (1990) Heritable major histocompatibility complex class II-associated differences in production of tumour necrosis factor α: Relevance to genetic predisposition to systemic lupus erythematosus. Proceedings of the National Academy of Sciences, 87, 1233.
11. Kunkel, L.M., Smith, K.D., Boyer, S.H., Borgaonkar, D.S., Wachtel, S.S., Miller, O.J., Breg, W.R., Jones, H.W., Jr & Rary, J.M. (1977) Analysis of human Y chromosome specified reiterated DNA in chromosome variants. Proceedings of the National Academy of Sciences, 74, 1245.
12. Lampeter, E.R., Kishimoto, T.K., Rothlein, R., Mainolsi, E.A., Bertram, J., Kolb, H. & Martin, S. (1992) Elevated levels of circulating adhesion molecules in IDDM patients and in subjects at risk for IDDM. Diabetes, 41, 1668.
13. McGuire, W., Hill, A.V.S., Allsopp, C.E.M., Greenwood, B.M. & Kwjatkowski, D. (1994) Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature, 371, 508.
14. Medcraft, J., Hitman, G.A., Sachs, J.A., Whichelow, C.E., Raafat, I. & Moore, R. (1993) Autoimmune renal disease and tumour necrosis factor β gene polymorphism. Clinical Nephrology, 40, 63.
15. Messer, G., Spengler, U., Jung, M.C., Honold, G., Blömer, K., Pape, G.R., Richtmuller, G. & Weiss, E.H. (1991) Polymorphic structure of the tumour necrosis factor (TNF) locus: an Ncol polymorphism in the first intron of the human TNF β gene correlates with a variant amino acid in position 26 and a reduced level of TNF β production. Journal of Experimental Medicine, 173, 209.
16. 2 shows stable interindividual differences. Scandinavian Journal of Immunology, 27, 705.
17. Paul, N. & Ruddle, N. (1988) Lymphotoxin. Annual Review of Immunology, 6, 407.
18. Pociot, F., Mølvig, J., Wogensen, L., Worsaae, H., Dalbøge, H., Back, L. & Nerup, J. (1991) A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scandinavian Journal of Immunology, 33, 37.
19. Pociot, F., Briant, L., Jongeneel, C.V., Mølvig, J., Worsaae, H., Abbal, M., Thomsen, M., Nerup, J. & Cambon-Thomsen, A. (1993) Association of tumour necrosis factor (TNF) and Class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. European Jounral of Immunology, 23, 224.
20. Raum, D., Awdeh, Z., Yunis, E.J., Alper, C.A. & Gabbay, K.H. (1984) Extended major histocompatibility complex haplotype in type I diabetes mellitus. Journal of Clinical Investigation, 74, 449.
21. Reed, K.C. & Mann, D.Q. (1985) Rapid transfer of DNA from agarose gels to nylon membranes. Nucleic Acid Research, 13, 7207.
22. Rosenau, W., Stites, D. & Jemtrud. S. (1979) Elaboration of lymphotoxin by freshly isolated human T lymphocytes and continuous lymphoid-cell lines. Cellular Immunology, 43, 235.
23. Roth, M.P., Nogueria, L., Coppin, H., Clanet, M., Clayton, J. & Cambon-Thomsen, A. (1994) Tumor necrosis factor polymorphism in multiple scleroris: no additional association independent of HLA. Journal of Neuroimmunology, 51(1): 93.
24. Sachs, J.A., Whichelow, C.E., Hitman, G.A., Niven, M.J., Thode, H. & Meager, A.J. (1990) The effect of HLA and insulin-indepedent diabetes mellitus on the secretion levels of tumour necrosis factors alpha and beta and gamma interferon. Scandinavian Journal of Immunology, 32, 703.
25. Satoh, J., Seino, H., Shintani, S., Tanaka, S., Ohtek, T., Masuda, T., Nobuaga, T. & Toyota, T. (1990) Inhibition of Type 1 diabetes in BB rats with recombinant human tumour necrosis factor α. Journal of Immunology, 145, 1395.
26. Satoh, J., Seino, H., Abo, T., Tanaka, S., Shintani, S., Ohta, S., Tamura, K., Sawai, T., Nobuaga, T., Otekit, T., Kumagai, K. & Toyota, T. (1989) Recombinant human tumour necrosis factor α suppresses autoimmune diabetes in Nonobese Diabetic mice. Journal of Clinical Investigation, 84, 1345.
27. Southern, E.M. (1975) Detection of specified sequencies among DNA fragments separated by gel electrophoresis. Journal of Molecular Biology, 98, 503.
28. Spies, T., Morton, C.C., Nedospasov, S.A., Fiers, W., Pious, D. & Strominger, J.L. (1986) Genes for the tumor necrosis factors α and β are linked to the human major histocompatibility complex. Proceedings of the National Academy of Sciences, 83, 8699.
29. Todd, J.A. (1990) Genetic control of autoimmunity in type 1 diabetes. Immunology Today, 11, 122.
30. Webb, G.C. & Chaplin, D.D. (1990) Genetic variability at the human tumour necrosis factor loci. Immunology, 145, 1278.
31. Williamson, B.D., Carswell, E.A., Rubin, B.Y., Prendergast, J.S. & Old, L.J. (1983) Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon. Proceedings of the National Academy of Sciences, 80, 5397.